Possible positive effect of the APOE ε2 allele on cognition in early to mid-adult life
- PMID: 29032015
- PMCID: PMC5725639
- DOI: 10.1016/j.nlm.2017.10.008
Possible positive effect of the APOE ε2 allele on cognition in early to mid-adult life
Abstract
Background: ε4 allele possession is associated with an increased risk of Alzheimer's disease. Its effects earlier in life are less well understood. Previous studies have reported both detrimental effects and a lack of effect on cognition outside dementia. We used genotype based recall from the ALSPAC study to investigate whether APOE genotype influences cognition in earlier adult life.
Methods: We invited all individuals with the rarer ε22 or ε44 genotypes and equal numbers of those with ε32, ε33 or ε34 APOE genotypes (total n invited = 1936, ages 23-67). Participants were screened for dementia using the Addenbrooke's Cognitive Examination Revised (ACE-R). Participants were asked to complete a 3 h battery of neuropsychological tests covering a range of cognitive domains. The primary outcome was performance on the Rey Auditory Verbal Learning Test (RAVLT). Transformation of variables was used where required to permit parametric testing. As genotypes are unlikely to be confounded unadjusted analyses were performed.
Results: 114 participants were recruited to the study (39 ε33, 27 ε34, 15 ε44, 26 ε32 & 7 ε22). ε4+ participants had higher scores on the cognitive failures questionnaire (10 point increase, p = 0.006) but no deficits on objective cognitive testing. ε2 carriers had slightly better episodic memory performance (p = 0.016), slightly improved n-back accuracy and better executive functioning (trails A&B, p = 0.005).
Conclusions: It is intriguing that the ε2+ group performed better as this group have a lower risk of Alzheimer's disease. Most previous studies have analysed as ε4/non ε4 so may have missed this effect.
Keywords: ALSPAC; Apolipoprotein E; Cognition; Executive functioning; Genetics; Memory episodic.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.
Figures
References
-
- Abdollahi M.R., Guthrie P.A.I., Smith G.D., Lawlor D.A., Ebrahim S., Day I.N.M. Integrated single-label liquid-phase assay of APOE codons 112 and 158 and a lipoprotein study in British women. Clinical Chemistry. 2006;52(7):1420–1423. - PubMed
-
- Alexander D.M., Williams L.M., Gatt J.M., Dobson-Stone C., Kuan S.A., Todd E.G.…Gordon E. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades. Biological Psychology. 2007;75(3):229–238. - PubMed
-
- Amaral-Carvalho V., Caramelli P. Normative data for healthy middle-aged and elderly performance on the addenbrooke cognitive examination-revised. Cognitive and Behavioral Neurology. 2012;25(2):72–76. - PubMed
-
- Amieva H., Le Goff M., Millet X., Orgogozo J.M., Pérès K., Barberger-Gateau P.…Dartigues J.F. Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms. Annals of Neurology. 2008;64(5):492–498. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
